Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Lauder

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Journal of Hypertension|June 30, 2021
Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or strokeMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
European Heart Journal|March 4, 2025
Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trialMichael Böhm, Javed Butler, Andrew Coats, et al.
Heart Rhythm|July 5, 2022
Renal denervation prevents subclinical atrial fibrillation in patients with hypertensive heart disease: Randomized, sham-controlled trialMarshall Heradien, Felix Mahfoud, Christeman Greyling, et al.
Journal of the American College of Cardiology|May 6, 2021
Changes in Plasma Renin Activity After Renal Artery Sympathetic DenervationFelix Mahfoud, Raymond R Townsend, David E Kandzari, et al.
Circulation|September 4, 2024
Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN TrialXiongjing Jiang, Felix Mahfoud, Wei Li, et al.
Nature Reviews. Cardiology|July 21, 2025
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practiceLucas Lauder, Thomas Weber, Michael Böhm, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 15, 2023
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Emanuele Barbato, Michel Azizi, Roland E Schmieder, et al.
European Heart Journal|February 15, 2023
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Emanuele Barbato, Michel Azizi, Roland E Schmieder, et al.
Journal of the American College of Cardiology|November 10, 2022
Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure RangeFelix Mahfoud, Giuseppe Mancia, Roland E Schmieder, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 13, 2016
Anatomical and procedural determinants of catheter-based renal denervationSebastian Ewen, Christian Ukena, Thomas Felix Lüscher, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Journal of Hypertension|June 30, 2021
Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or strokeMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
European Heart Journal|March 4, 2025
Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trialMichael Böhm, Javed Butler, Andrew Coats, et al.
Heart Rhythm|July 5, 2022
Renal denervation prevents subclinical atrial fibrillation in patients with hypertensive heart disease: Randomized, sham-controlled trialMarshall Heradien, Felix Mahfoud, Christeman Greyling, et al.
Journal of the American College of Cardiology|May 6, 2021
Changes in Plasma Renin Activity After Renal Artery Sympathetic DenervationFelix Mahfoud, Raymond R Townsend, David E Kandzari, et al.
Circulation|September 4, 2024
Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN TrialXiongjing Jiang, Felix Mahfoud, Wei Li, et al.
Nature Reviews. Cardiology|July 21, 2025
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practiceLucas Lauder, Thomas Weber, Michael Böhm, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 15, 2023
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Emanuele Barbato, Michel Azizi, Roland E Schmieder, et al.
European Heart Journal|February 15, 2023
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Emanuele Barbato, Michel Azizi, Roland E Schmieder, et al.
Journal of the American College of Cardiology|November 10, 2022
Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure RangeFelix Mahfoud, Giuseppe Mancia, Roland E Schmieder, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 13, 2016
Anatomical and procedural determinants of catheter-based renal denervationSebastian Ewen, Christian Ukena, Thomas Felix Lüscher, et al.
Pageof 11